EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dysphagia as the Initial Manifestation of Anti‐HMGCR Antibody–Positive Immune‐Mediated Necrotizing Myopathy Complicated by Pulmonary Embolism

Rohini Kalluri iD, Elena Ciofoaia iD, Omobolanle Adetimehin, Aryan Shiari iD, Igor Dumic iD, Margherita Milone iD, Juan Vera Gomez iD, Erik Sviggum, Celestine Odenigbo, Cristian Madrid iD, Charles W Nordstrom iD

Case Reports in Rheumatology · 2026-01 · 2026 (1)

DOI: 10.1155/crrh/2235175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Rheumatology, online erschienen am 03.11.2026. Verfasst von Rohini Kalluri und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine Mayo Clinic Health System Eau Claire Wisconsin USA mayoclinichealthsystem.org. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anti–3‐hydroxy‐3‐methylglutaryl–coenzyme A reductase (anti‐HMGCR) antibody–positive immune‐mediated necrotizing myopathy (IMNM) is a rare autoimmune myopathy characterized by progressive proximal muscle weakness and markedly elevated creatine kinase levels. Although commonly associated with prior statin exposure, statin‐naïve cases and atypical presentations are well described. Patients with idiopathic inflammatory myopathies are also at increased risk for venous thromboembolism (VTE), though data specific to IMNM remain limited. Case Presentation An 83‐year‐old man with brief, remote statin exposure presented with progressive proximal muscle weakness and a three‐year history of oropharyngeal dysphagia preceding limb involvement. Laboratory evaluation revealed markedly elevated creatine kinase and transaminases. Anti‐HMGCR antibodies were positive, and muscle biopsy confirmed necrotizing myopathy. During evaluation for occult malignancy, bilateral pulmonary emboli were incidentally identified. The patient required high‐dose corticosteroids, mycophenolate mofetil, and intravenous immunoglobulin for refractory disease. With aggressive immunosuppressive therapy and rehabilitation, he demonstrated substantial clinical recovery at 6 months.

Conclusion

This case highlights oropharyngeal dysphagia as an early and, for a prolonged period, isolated manifestation of anti‐HMGCR antibody–positive IMNM; here, it preceded the onset of limb weakness by approximately 3 years. It underscores the importance of comprehensive diagnostic evaluation in patients with unexplained oropharyngeal dysfunction, in whom an inflammatory myopathy may otherwise be overlooked for years. Clinicians should maintain awareness of thrombotic risk in inflammatory myopathies, particularly during active disease. Early recognition and prompt immunosuppressive therapy remain critical to optimize outcomes and prevent irreversible muscle damage.

Autor:innen und Institutionen

  • Department of Family Medicine Mayo Clinic Health System Eau Claire Wisconsin USA mayoclinichealthsystem.org.
  • Department of Rheumatology Mayo Clinic Health System Eau Claire Wisconsin USA mayoclinichealthsystem.org.
  • Department of Hospital Internal Medicine Mayo Clinic Health System Eau Claire Wisconsin USA mayoclinichealthsystem.org.
  • Department of Pulmonary and Critical Care Medicine Mayo Clinic Health System Eau Claire Wisconsin USA mayoclinichealthsystem.org.
  • Department of Neurology Mayo Clinic Rochester Minnesota USA mayo.edu.
  • Department of Radiology Mayo Clinic Health System Eau Claire Wisconsin USA mayoclinichealthsystem.org.

ORCID-Profile: Rohini Kalluri, Elena Ciofoaia, Aryan Shiari, Igor Dumic, Margherita Milone, Juan Vera Gomez, Cristian Madrid, Charles W Nordstrom

Zitieren

APA

Kalluri, R., Ciofoaia, E., Adetimehin, O., Shiari, A., Dumic, I., Milone, M., Gomez, J. V., Sviggum, E., Odenigbo, C., Madrid, C., & Nordstrom, C. W. (2026). Dysphagia as the Initial Manifestation of Anti‐HMGCR Antibody–Positive Immune‐Mediated Necrotizing Myopathy Complicated by Pulmonary Embolism. Case Reports in Rheumatology, 2026(1). https://doi.org/10.1155/crrh/2235175

Vancouver

Kalluri R, Ciofoaia E, Adetimehin O, Shiari A, Dumic I, Milone M, et al. Dysphagia as the Initial Manifestation of Anti‐HMGCR Antibody–Positive Immune‐Mediated Necrotizing Myopathy Complicated by Pulmonary Embolism. Case Reports in Rheumatology. 2026;2026(1). doi:10.1155/crrh/2235175

BibTeX
@article{Kalluri2026,
  author = {Kalluri, Rohini and Ciofoaia, Elena and Adetimehin, Omobolanle and Shiari, Aryan and Dumic, Igor and Milone, Margherita and Gomez, Juan Vera and Sviggum, Erik and Odenigbo, Celestine and Madrid, Cristian and Nordstrom, Charles W},
  title = {Dysphagia as the Initial Manifestation of Anti‐HMGCR Antibody–Positive Immune‐Mediated Necrotizing Myopathy Complicated by Pulmonary Embolism},
  journal = {Case Reports in Rheumatology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crrh/2235175}
}
Kostenlos starten →